NCT03510923

Brief Summary

The FANCY study will investigate whether a selective policy of histopathological examination of appendices and gallbladders based on the intraoperative findings of the surgeon is safe and cost-effective.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17,380

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 27, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2020

Completed
Last Updated

June 4, 2024

Status Verified

June 1, 2024

Enrollment Period

1.8 years

First QC Date

April 18, 2018

Last Update Submit

June 1, 2024

Conditions

Keywords

AppendixAppendectomyGallbladderCholecystectomyNeoplasmsPathologySelectiveRoutine

Outcome Measures

Primary Outcomes (2)

  • Unnoticed neoplasms requiring additional therapy benefitting the patient

    Number of patients per 1000 examined appendices/gallbladders with a neoplasm requiring additional therapy benefitting the patient that would have been unnoticed in the policy of selective histopathological examination.

    3 months

  • Costs

    Costs of the policy with selective and with routine histopathological examination of the appendix/gallbladder.

    3 months

Secondary Outcomes (7)

  • Malignancies

    2 weeks

  • Unnoticed malignancies

    2 weeks

  • Malignancies requiring more extensive resection or other additional treatment

    3 months

  • Benefit of additional resection

    2 weeks

  • Harm of additional resection

    1 month

  • +2 more secondary outcomes

Study Arms (2)

Patients who underwent an appendectomy

Patients of all ages who underwent an appendectomy in the elective or non-elective setting.

Other: Inspection and palpation of the appendix

Patients who underwent a cholecystectomy

Patients of all ages who underwent a cholecystectomy in the elective or non-elective setting.

Other: Inspection and palpation of the gallbladder

Interventions

The removed appendix will be evaluated for tumours by the operating surgeon by visual inspection and digital palpation of the specimen. The appendix will not be opened. The surgeon will report his or her findings on a predefined scoring form: he or she will report all abnormalities and writes down whether he or she considers there is an indication for histopathological examination. Subsequently, all specimens will be sent for histopathological examination. Histopathological examination will be conducted according to the local protocol. In case of a neoplasm of the appendix, the treatment strategy is discussed and decided by the local multidisciplinary team. If an additional more extensive resection is decided to be appropriate, the specimens of the re-resection will be evaluated for the presence of remaining tumour tissue.

Patients who underwent an appendectomy

The removed gallbladder will be evaluated for tumours by the operating surgeon by visual inspection and digital palpation of the specimen. The gallbladder is opened in its length, without cutting the cystic duct, and is inspected and palpated. The surgeon will report his or her findings on a predefined scoring form: he or she will report all abnormalities and writes down whether he or she considers there is an indication for histopathological examination. Subsequently, all specimens will be sent for histopathological examination. Histopathological examination will be conducted according to the local protocol. In case of a neoplasm of the gallbladder, the treatment strategy is discussed and decided by the local multidisciplinary team. If an additional more extensive resection is decided to be appropriate, the specimens of the re-resection will be evaluated for the presence of remaining tumour tissue.

Patients who underwent a cholecystectomy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are scheduled to undergo an appendectomy or cholecystectomy in one of the participating centers in The Netherlands.

You may qualify if:

  • Patients scheduled to undergo an appendectomy or cholecystectomy in the elective or non-elective setting.

You may not qualify if:

  • Primary indication for surgery: strong suspicion or proven malignancy in the appendix or gallbladder.
  • Appendix or gallbladder removed as part of more extensive surgery, so-called incidental appendectomies or cholecystectomies.
  • Patients included in the ACCURE trial (effect of appendectomy on ulcerative colitis).
  • The presence of a gallbladder polyp of \>10 mm on preoperative imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Academic Medical Center

Amsterdam-Zuidoost, 1105 AZ, Netherlands

Location

Related Publications (1)

  • Bastiaenen VP, Corten BJ, de Savornin Lohman EA, de Jonge J, Kraima AC, Swank HA, van Vliet JL, van Acker GJ, van Geloven AA, In 't Hof KH, Koens L, de Reuver PR, van Rossem CC, Slooter GD, Tanis PJ, Terpstra V, Dijkgraaf MG, Bemelman WA. Safety and cost analysis of selective histopathological examination following appendicectomy and cholecystectomy (FANCY study): protocol and statistical analysis plan of a prospective observational multicentre study. BMJ Open. 2019 Dec 23;9(12):e035912. doi: 10.1136/bmjopen-2019-035912.

MeSH Terms

Conditions

Appendiceal NeoplasmsGallbladder NeoplasmsNeoplasms

Interventions

Watchful Waiting

Condition Hierarchy (Ancestors)

Cecal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesCecal DiseasesIntestinal DiseasesBiliary Tract NeoplasmsBiliary Tract DiseasesGallbladder Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services Administration

Study Officials

  • Willem Bemelman, Professor

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 18, 2018

First Posted

April 27, 2018

Study Start

May 1, 2018

Primary Completion

February 1, 2020

Study Completion

December 24, 2020

Last Updated

June 4, 2024

Record last verified: 2024-06

Locations